nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—Corticosteroid Hormone Receptor Agonists—Prednisolone—chronic obstructive pulmonary disease	0.263	1	CiPCiCtD
Prednisone—asthma—chronic obstructive pulmonary disease	0.21	1	CtDrD
Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.179	1	CrCtD
Prednisone—ALB—chronic obstructive pulmonary disease	0.0648	1	CbGaD
Prednisone—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0177	0.211	CbGbCtD
Prednisone—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0153	0.182	CbGbCtD
Prednisone—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0115	0.137	CbGbCtD
Prednisone—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0115	0.137	CbGbCtD
Prednisone—Exemestane—Prednisolone—chronic obstructive pulmonary disease	0.00958	0.0692	CrCrCtD
Prednisone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00733	0.0875	CbGbCtD
Prednisone—Potassium Canrenoate—Prednisolone—chronic obstructive pulmonary disease	0.00725	0.0523	CrCrCtD
Prednisone—Ciclesonide—Prednisolone—chronic obstructive pulmonary disease	0.00637	0.046	CrCrCtD
Prednisone—Hydrocortamate—Prednisolone—chronic obstructive pulmonary disease	0.00533	0.0384	CrCrCtD
Prednisone—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.00516	0.0373	CrCrCtD
Prednisone—Prednicarbate—Prednisolone—chronic obstructive pulmonary disease	0.00501	0.0362	CrCrCtD
Prednisone—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.00501	0.0362	CrCrCtD
Prednisone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00495	0.0591	CbGbCtD
Prednisone—Fluocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00487	0.0351	CrCrCtD
Prednisone—Alclometasone—Prednisolone—chronic obstructive pulmonary disease	0.00473	0.0341	CrCrCtD
Prednisone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00472	0.0564	CbGbCtD
Prednisone—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.0046	0.0332	CrCrCtD
Prednisone—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.0046	0.0332	CrCrCtD
Prednisone—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00449	0.0324	CrCrCtD
Prednisone—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00449	0.0324	CrCrCtD
Prednisone—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00449	0.0324	CrCrCtD
Prednisone—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00449	0.0324	CrCrCtD
Prednisone—Desonide—Prednisolone—chronic obstructive pulmonary disease	0.00449	0.0324	CrCrCtD
Prednisone—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.00437	0.0316	CrCrCtD
Prednisone—Paramethasone—Prednisolone—chronic obstructive pulmonary disease	0.00437	0.0316	CrCrCtD
Prednisone—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00427	0.0308	CrCrCtD
Prednisone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00421	0.0503	CbGbCtD
Prednisone—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.00417	0.0301	CrCrCtD
Prednisone—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.00417	0.0301	CrCrCtD
Prednisone—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.00417	0.0301	CrCrCtD
Prednisone—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00417	0.0301	CrCrCtD
Prednisone—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.00417	0.0301	CrCrCtD
Prednisone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00412	0.0492	CbGbCtD
Prednisone—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00407	0.0294	CrCrCtD
Prednisone—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.00407	0.0294	CrCrCtD
Prednisone—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00407	0.0294	CrCrCtD
Prednisone—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.00389	0.0281	CrCrCtD
Prednisone—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00366	0.0264	CrCrCtD
Prednisone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00247	0.0295	CbGbCtD
Prednisone—HSD11B1—respiratory system—chronic obstructive pulmonary disease	0.000952	0.165	CbGeAlD
Prednisone—HSD11B1—connective tissue—chronic obstructive pulmonary disease	0.000838	0.145	CbGeAlD
Prednisone—HSD11B1—bronchus—chronic obstructive pulmonary disease	0.000783	0.136	CbGeAlD
Prednisone—HSD11B1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000766	0.133	CbGeAlD
Prednisone—HSD11B1—trachea—chronic obstructive pulmonary disease	0.000703	0.122	CbGeAlD
Prednisone—HSD11B1—lung—chronic obstructive pulmonary disease	0.000505	0.0874	CbGeAlD
Prednisone—NR3C1—respiratory system—chronic obstructive pulmonary disease	0.00018	0.0312	CbGeAlD
Prednisone—NR3C1—connective tissue—chronic obstructive pulmonary disease	0.000159	0.0274	CbGeAlD
Prednisone—SLCO1A2—lung—chronic obstructive pulmonary disease	0.000153	0.0264	CbGeAlD
Prednisone—NR3C1—bronchus—chronic obstructive pulmonary disease	0.000148	0.0256	CbGeAlD
Prednisone—NR3C1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000145	0.0251	CbGeAlD
Prednisone—NR3C1—trachea—chronic obstructive pulmonary disease	0.000133	0.023	CbGeAlD
Prednisone—ABCB1—respiratory system—chronic obstructive pulmonary disease	9.64e-05	0.0167	CbGeAlD
Prednisone—NR3C1—lung—chronic obstructive pulmonary disease	9.56e-05	0.0165	CbGeAlD
Prednisone—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	7.13e-05	0.284	CrCbGaD
Prednisone—ABCB1—trachea—chronic obstructive pulmonary disease	7.13e-05	0.0123	CbGeAlD
Prednisone—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	6.87e-05	0.273	CrCbGaD
Prednisone—Dexamethasone—NOS2—chronic obstructive pulmonary disease	5.81e-05	0.231	CrCbGaD
Prednisone—ABCB1—lung—chronic obstructive pulmonary disease	5.12e-05	0.00886	CbGeAlD
Prednisone—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	5.05e-05	0.00121	CcSEcCtD
Prednisone—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	5.05e-05	0.00121	CcSEcCtD
Prednisone—Vomiting—Roflumilast—chronic obstructive pulmonary disease	5.03e-05	0.00121	CcSEcCtD
Prednisone—Anorexia—Aminophylline—chronic obstructive pulmonary disease	5.03e-05	0.00121	CcSEcCtD
Prednisone—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	5e-05	0.0012	CcSEcCtD
Prednisone—Rash—Roflumilast—chronic obstructive pulmonary disease	4.99e-05	0.0012	CcSEcCtD
Prednisone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	4.98e-05	0.0012	CcSEcCtD
Prednisone—Oedema—Tiotropium—chronic obstructive pulmonary disease	4.97e-05	0.00119	CcSEcCtD
Prednisone—Headache—Roflumilast—chronic obstructive pulmonary disease	4.95e-05	0.00119	CcSEcCtD
Prednisone—Flushing—Salbutamol—chronic obstructive pulmonary disease	4.95e-05	0.00119	CcSEcCtD
Prednisone—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	4.95e-05	0.00119	CcSEcCtD
Prednisone—Mental disorder—Formoterol—chronic obstructive pulmonary disease	4.95e-05	0.00119	CcSEcCtD
Prednisone—Infection—Tiotropium—chronic obstructive pulmonary disease	4.94e-05	0.00119	CcSEcCtD
Prednisone—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	4.92e-05	0.00118	CcSEcCtD
Prednisone—Malnutrition—Formoterol—chronic obstructive pulmonary disease	4.92e-05	0.00118	CcSEcCtD
Prednisone—Shock—Tiotropium—chronic obstructive pulmonary disease	4.89e-05	0.00117	CcSEcCtD
Prednisone—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	4.88e-05	0.00117	CcSEcCtD
Prednisone—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	4.88e-05	0.00117	CcSEcCtD
Prednisone—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	4.85e-05	0.00117	CcSEcCtD
Prednisone—Mental disorder—Montelukast—chronic obstructive pulmonary disease	4.85e-05	0.00116	CcSEcCtD
Prednisone—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	4.84e-05	0.00116	CcSEcCtD
Prednisone—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	4.83e-05	0.00116	CcSEcCtD
Prednisone—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	4.82e-05	0.00116	CcSEcCtD
Prednisone—Injury—Prednisolone—chronic obstructive pulmonary disease	4.81e-05	0.00116	CcSEcCtD
Prednisone—Insomnia—Aminophylline—chronic obstructive pulmonary disease	4.77e-05	0.00115	CcSEcCtD
Prednisone—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	4.76e-05	0.00114	CcSEcCtD
Prednisone—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	4.71e-05	0.00113	CcSEcCtD
Prednisone—Nausea—Roflumilast—chronic obstructive pulmonary disease	4.7e-05	0.00113	CcSEcCtD
Prednisone—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	4.67e-05	0.00112	CcSEcCtD
Prednisone—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	4.64e-05	0.00111	CcSEcCtD
Prednisone—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	4.64e-05	0.00111	CcSEcCtD
Prednisone—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	4.58e-05	0.0011	CcSEcCtD
Prednisone—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	4.56e-05	0.0011	CcSEcCtD
Prednisone—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	4.56e-05	0.0011	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	4.53e-05	0.00109	CcSEcCtD
Prednisone—Agitation—Formoterol—chronic obstructive pulmonary disease	4.52e-05	0.00108	CcSEcCtD
Prednisone—Agitation—Arformoterol—chronic obstructive pulmonary disease	4.52e-05	0.00108	CcSEcCtD
Prednisone—Insomnia—Tiotropium—chronic obstructive pulmonary disease	4.5e-05	0.00108	CcSEcCtD
Prednisone—Angioedema—Arformoterol—chronic obstructive pulmonary disease	4.49e-05	0.00108	CcSEcCtD
Prednisone—Angioedema—Formoterol—chronic obstructive pulmonary disease	4.49e-05	0.00108	CcSEcCtD
Prednisone—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	4.47e-05	0.00324	CbGpPWpGaD
Prednisone—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	4.46e-05	0.00107	CcSEcCtD
Prednisone—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	4.45e-05	0.00322	CbGpPWpGaD
Prednisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	4.44e-05	0.00322	CbGpPWpGaD
Prednisone—Malaise—Arformoterol—chronic obstructive pulmonary disease	4.43e-05	0.00106	CcSEcCtD
Prednisone—Malaise—Formoterol—chronic obstructive pulmonary disease	4.43e-05	0.00106	CcSEcCtD
Prednisone—Agitation—Montelukast—chronic obstructive pulmonary disease	4.43e-05	0.00106	CcSEcCtD
Prednisone—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	4.42e-05	0.0032	CbGpPWpGaD
Prednisone—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	4.42e-05	0.00106	CcSEcCtD
Prednisone—Angioedema—Montelukast—chronic obstructive pulmonary disease	4.4e-05	0.00106	CcSEcCtD
Prednisone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	4.38e-05	0.00105	CcSEcCtD
Prednisone—Affect lability—Prednisolone—chronic obstructive pulmonary disease	4.35e-05	0.00105	CcSEcCtD
Prednisone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	4.31e-05	0.00104	CcSEcCtD
Prednisone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	4.31e-05	0.00103	CcSEcCtD
Prednisone—HSD11B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.29e-05	0.00311	CbGpPWpGaD
Prednisone—Agitation—Salbutamol—chronic obstructive pulmonary disease	4.27e-05	0.00102	CcSEcCtD
Prednisone—Constipation—Tiotropium—chronic obstructive pulmonary disease	4.25e-05	0.00102	CcSEcCtD
Prednisone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	4.24e-05	0.00102	CcSEcCtD
Prednisone—Hypertension—Formoterol—chronic obstructive pulmonary disease	4.24e-05	0.00102	CcSEcCtD
Prednisone—Angioedema—Salbutamol—chronic obstructive pulmonary disease	4.24e-05	0.00102	CcSEcCtD
Prednisone—HSD11B1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.24e-05	0.00307	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	4.24e-05	0.00307	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	4.23e-05	0.00307	CbGpPWpGaD
Prednisone—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	4.2e-05	0.00101	CcSEcCtD
Prednisone—Mood swings—Prednisolone—chronic obstructive pulmonary disease	4.19e-05	0.00101	CcSEcCtD
Prednisone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	4.19e-05	0.00101	CcSEcCtD
Prednisone—Malaise—Salbutamol—chronic obstructive pulmonary disease	4.19e-05	0.00101	CcSEcCtD
Prednisone—Arthralgia—Formoterol—chronic obstructive pulmonary disease	4.19e-05	0.00101	CcSEcCtD
Prednisone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	4.19e-05	0.00101	CcSEcCtD
Prednisone—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	4.19e-05	0.00101	CcSEcCtD
Prednisone—Myalgia—Formoterol—chronic obstructive pulmonary disease	4.19e-05	0.00101	CcSEcCtD
Prednisone—Convulsion—Montelukast—chronic obstructive pulmonary disease	4.17e-05	0.001	CcSEcCtD
Prednisone—Anxiety—Formoterol—chronic obstructive pulmonary disease	4.17e-05	0.001	CcSEcCtD
Prednisone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	4.17e-05	0.001	CcSEcCtD
Prednisone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	4.17e-05	0.001	CcSEcCtD
Prednisone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	4.17e-05	0.001	CcSEcCtD
Prednisone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	4.17e-05	0.001	CcSEcCtD
Prednisone—Syncope—Salbutamol—chronic obstructive pulmonary disease	4.16e-05	0.001	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	4.16e-05	0.000998	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	4.16e-05	0.000998	CcSEcCtD
Prednisone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	4.14e-05	0.000993	CcSEcCtD
Prednisone—Discomfort—Formoterol—chronic obstructive pulmonary disease	4.14e-05	0.000993	CcSEcCtD
Prednisone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	4.1e-05	0.000985	CcSEcCtD
Prednisone—Myalgia—Montelukast—chronic obstructive pulmonary disease	4.1e-05	0.000985	CcSEcCtD
Prednisone—Anxiety—Montelukast—chronic obstructive pulmonary disease	4.09e-05	0.000981	CcSEcCtD
Prednisone—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	4.08e-05	0.00098	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	4.07e-05	0.000978	CcSEcCtD
Prednisone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	4.07e-05	0.000976	CcSEcCtD
Prednisone—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	4.07e-05	0.00295	CbGpPWpGaD
Prednisone—Dry skin—Prednisolone—chronic obstructive pulmonary disease	4.05e-05	0.000973	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	4.04e-05	0.00293	CbGpPWpGaD
Prednisone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	4.01e-05	0.000964	CcSEcCtD
Prednisone—Oedema—Arformoterol—chronic obstructive pulmonary disease	4.01e-05	0.000964	CcSEcCtD
Prednisone—Oedema—Formoterol—chronic obstructive pulmonary disease	4.01e-05	0.000964	CcSEcCtD
Prednisone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	4.01e-05	0.000964	CcSEcCtD
Prednisone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	4.01e-05	0.000963	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	4e-05	0.0029	CbGpPWpGaD
Prednisone—Infection—Formoterol—chronic obstructive pulmonary disease	3.99e-05	0.000957	CcSEcCtD
Prednisone—Infection—Arformoterol—chronic obstructive pulmonary disease	3.99e-05	0.000957	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	3.97e-05	0.00288	CbGpPWpGaD
Prednisone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	3.95e-05	0.000949	CcSEcCtD
Prednisone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	3.95e-05	0.000949	CcSEcCtD
Prednisone—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	3.95e-05	0.00286	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.95e-05	0.00286	CbGpPWpGaD
Prednisone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	3.95e-05	0.000949	CcSEcCtD
Prednisone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	3.94e-05	0.000946	CcSEcCtD
Prednisone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	3.94e-05	0.000945	CcSEcCtD
Prednisone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	3.94e-05	0.000945	CcSEcCtD
Prednisone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	3.93e-05	0.000944	CcSEcCtD
Prednisone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	3.93e-05	0.000944	CcSEcCtD
Prednisone—Oedema—Montelukast—chronic obstructive pulmonary disease	3.93e-05	0.000944	CcSEcCtD
Prednisone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	3.92e-05	0.00094	CcSEcCtD
Prednisone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	3.92e-05	0.00094	CcSEcCtD
Prednisone—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	3.91e-05	0.00283	CbGpPWpGaD
Prednisone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	3.91e-05	0.000938	CcSEcCtD
Prednisone—Infection—Montelukast—chronic obstructive pulmonary disease	3.9e-05	0.000938	CcSEcCtD
Prednisone—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	3.9e-05	0.000936	CcSEcCtD
Prednisone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	3.9e-05	0.000936	CcSEcCtD
Prednisone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	3.9e-05	0.000936	CcSEcCtD
Prednisone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	3.88e-05	0.000933	CcSEcCtD
Prednisone—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	3.88e-05	0.00281	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.87e-05	0.0028	CbGpPWpGaD
Prednisone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	3.86e-05	0.0028	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	3.86e-05	0.00279	CbGpPWpGaD
Prednisone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	3.85e-05	0.000926	CcSEcCtD
Prednisone—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	3.85e-05	0.000924	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	3.84e-05	0.00278	CbGpPWpGaD
Prednisone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	3.82e-05	0.000917	CcSEcCtD
Prednisone—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	3.81e-05	0.00276	CbGpPWpGaD
Prednisone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	3.79e-05	0.00091	CcSEcCtD
Prednisone—Oedema—Salbutamol—chronic obstructive pulmonary disease	3.79e-05	0.00091	CcSEcCtD
Prednisone—Infection—Salbutamol—chronic obstructive pulmonary disease	3.76e-05	0.000904	CcSEcCtD
Prednisone—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	3.75e-05	0.0009	CcSEcCtD
Prednisone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	3.73e-05	0.000896	CcSEcCtD
Prednisone—Shock—Salbutamol—chronic obstructive pulmonary disease	3.73e-05	0.000895	CcSEcCtD
Prednisone—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	3.72e-05	0.0027	CbGpPWpGaD
Prednisone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	3.72e-05	0.000894	CcSEcCtD
Prednisone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	3.72e-05	0.000892	CcSEcCtD
Prednisone—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	3.71e-05	0.00269	CbGpPWpGaD
Prednisone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	3.7e-05	0.000888	CcSEcCtD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	3.69e-05	0.00267	CbGpPWpGaD
Prednisone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	3.68e-05	0.000884	CcSEcCtD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	3.67e-05	0.00266	CbGpPWpGaD
Prednisone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	3.66e-05	0.00088	CcSEcCtD
Prednisone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	3.66e-05	0.00088	CcSEcCtD
Prednisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	3.66e-05	0.00265	CbGpPWpGaD
Prednisone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	3.66e-05	0.000878	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	3.66e-05	0.000878	CcSEcCtD
Prednisone—Insomnia—Formoterol—chronic obstructive pulmonary disease	3.63e-05	0.000872	CcSEcCtD
Prednisone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	3.63e-05	0.000872	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	3.61e-05	0.00262	CbGpPWpGaD
Prednisone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	3.61e-05	0.000867	CcSEcCtD
Prednisone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	3.61e-05	0.000866	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	3.58e-05	0.00086	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	3.56e-05	0.00258	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.56e-05	0.00258	CbGpPWpGaD
Prednisone—Insomnia—Montelukast—chronic obstructive pulmonary disease	3.55e-05	0.000854	CcSEcCtD
Prednisone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	3.53e-05	0.000848	CcSEcCtD
Prednisone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	3.53e-05	0.000848	CcSEcCtD
Prednisone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	3.53e-05	0.000847	CcSEcCtD
Prednisone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	3.52e-05	0.000845	CcSEcCtD
Prednisone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	3.49e-05	0.000837	CcSEcCtD
Prednisone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	3.48e-05	0.000835	CcSEcCtD
Prednisone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	3.46e-05	0.000831	CcSEcCtD
Prednisone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	3.46e-05	0.000831	CcSEcCtD
Prednisone—Fatigue—Formoterol—chronic obstructive pulmonary disease	3.46e-05	0.000831	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	3.45e-05	0.000829	CcSEcCtD
Prednisone—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	3.43e-05	0.00249	CbGpPWpGaD
Prednisone—Constipation—Arformoterol—chronic obstructive pulmonary disease	3.43e-05	0.000824	CcSEcCtD
Prednisone—Constipation—Formoterol—chronic obstructive pulmonary disease	3.43e-05	0.000824	CcSEcCtD
Prednisone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	3.43e-05	0.000823	CcSEcCtD
Prednisone—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	3.41e-05	0.00247	CbGpPWpGaD
Prednisone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	3.4e-05	0.000817	CcSEcCtD
Prednisone—Fatigue—Montelukast—chronic obstructive pulmonary disease	3.39e-05	0.000814	CcSEcCtD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	3.38e-05	0.00245	CbGpPWpGaD
Prednisone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	3.36e-05	0.000807	CcSEcCtD
Prednisone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	3.35e-05	0.000805	CcSEcCtD
Prednisone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	3.34e-05	0.000802	CcSEcCtD
Prednisone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	3.34e-05	0.000802	CcSEcCtD
Prednisone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	3.34e-05	0.000801	CcSEcCtD
Prednisone—Rash—Aminophylline—chronic obstructive pulmonary disease	3.32e-05	0.000798	CcSEcCtD
Prednisone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	3.32e-05	0.000798	CcSEcCtD
Prednisone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	3.31e-05	0.000794	CcSEcCtD
Prednisone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	3.31e-05	0.000794	CcSEcCtD
Prednisone—Headache—Aminophylline—chronic obstructive pulmonary disease	3.3e-05	0.000793	CcSEcCtD
Prednisone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	3.29e-05	0.000791	CcSEcCtD
Prednisone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	3.29e-05	0.00079	CcSEcCtD
Prednisone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	3.28e-05	0.000788	CcSEcCtD
Prednisone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	3.28e-05	0.000788	CcSEcCtD
Prednisone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	3.27e-05	0.000784	CcSEcCtD
Prednisone—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	3.25e-05	0.00235	CbGpPWpGaD
Prednisone—Constipation—Salbutamol—chronic obstructive pulmonary disease	3.24e-05	0.000778	CcSEcCtD
Prednisone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	3.21e-05	0.000772	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.21e-05	0.00232	CbGpPWpGaD
Prednisone—Urticaria—Formoterol—chronic obstructive pulmonary disease	3.19e-05	0.000765	CcSEcCtD
Prednisone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	3.19e-05	0.000765	CcSEcCtD
Prednisone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	3.17e-05	0.000762	CcSEcCtD
Prednisone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	3.17e-05	0.000762	CcSEcCtD
Prednisone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	3.17e-05	0.000762	CcSEcCtD
Prednisone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	3.17e-05	0.000762	CcSEcCtD
Prednisone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	3.16e-05	0.000759	CcSEcCtD
Prednisone—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	3.16e-05	0.00229	CbGpPWpGaD
Prednisone—Rash—Tiotropium—chronic obstructive pulmonary disease	3.14e-05	0.000753	CcSEcCtD
Prednisone—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	3.13e-05	0.00227	CbGpPWpGaD
Prednisone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	3.13e-05	0.000752	CcSEcCtD
Prednisone—Nausea—Aminophylline—chronic obstructive pulmonary disease	3.13e-05	0.000752	CcSEcCtD
Prednisone—Urticaria—Montelukast—chronic obstructive pulmonary disease	3.12e-05	0.00075	CcSEcCtD
Prednisone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	3.12e-05	0.00075	CcSEcCtD
Prednisone—Headache—Tiotropium—chronic obstructive pulmonary disease	3.11e-05	0.000748	CcSEcCtD
Prednisone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	3.11e-05	0.000748	CcSEcCtD
Prednisone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	3.11e-05	0.000746	CcSEcCtD
Prednisone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	3.11e-05	0.000746	CcSEcCtD
Prednisone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	3.1e-05	0.000744	CcSEcCtD
Prednisone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	3.07e-05	0.000738	CcSEcCtD
Prednisone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	3.06e-05	0.000735	CcSEcCtD
Prednisone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	3.01e-05	0.000723	CcSEcCtD
Prednisone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	3e-05	0.000719	CcSEcCtD
Prednisone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	3e-05	0.000719	CcSEcCtD
Prednisone—HSD11B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.97e-05	0.00215	CbGpPWpGaD
Prednisone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	2.96e-05	0.00071	CcSEcCtD
Prednisone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	2.96e-05	0.00071	CcSEcCtD
Prednisone—Nausea—Tiotropium—chronic obstructive pulmonary disease	2.95e-05	0.000709	CcSEcCtD
Prednisone—HSD11B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.93e-05	0.00212	CbGpPWpGaD
Prednisone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	2.9e-05	0.000695	CcSEcCtD
Prednisone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	2.88e-05	0.000691	CcSEcCtD
Prednisone—Asthenia—Formoterol—chronic obstructive pulmonary disease	2.88e-05	0.000691	CcSEcCtD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	2.87e-05	0.00208	CbGpPWpGaD
Prednisone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	2.87e-05	0.00208	CbGpPWpGaD
Prednisone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	2.84e-05	0.000682	CcSEcCtD
Prednisone—Pruritus—Formoterol—chronic obstructive pulmonary disease	2.84e-05	0.000682	CcSEcCtD
Prednisone—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	2.84e-05	0.00206	CbGpPWpGaD
Prednisone—Asthenia—Montelukast—chronic obstructive pulmonary disease	2.82e-05	0.000677	CcSEcCtD
Prednisone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	2.81e-05	0.00203	CbGpPWpGaD
Prednisone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	2.79e-05	0.00067	CcSEcCtD
Prednisone—Pruritus—Montelukast—chronic obstructive pulmonary disease	2.78e-05	0.000668	CcSEcCtD
Prednisone—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	2.77e-05	0.00201	CbGpPWpGaD
Prednisone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	2.75e-05	0.000659	CcSEcCtD
Prednisone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	2.75e-05	0.000659	CcSEcCtD
Prednisone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	2.73e-05	0.000656	CcSEcCtD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	2.73e-05	0.00198	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.73e-05	0.00198	CbGpPWpGaD
Prednisone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	2.72e-05	0.000653	CcSEcCtD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	2.71e-05	0.00196	CbGpPWpGaD
Prednisone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	2.69e-05	0.000646	CcSEcCtD
Prednisone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	2.68e-05	0.000644	CcSEcCtD
Prednisone—Dexamethasone—CYP1A1—chronic obstructive pulmonary disease	2.67e-05	0.106	CrCbGaD
Prednisone—Erythema—Prednisolone—chronic obstructive pulmonary disease	2.66e-05	0.000639	CcSEcCtD
Prednisone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	2.65e-05	0.000637	CcSEcCtD
Prednisone—Dizziness—Formoterol—chronic obstructive pulmonary disease	2.65e-05	0.000637	CcSEcCtD
Prednisone—Methyltestosterone—ALB—chronic obstructive pulmonary disease	2.65e-05	0.105	CrCbGaD
Prednisone—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	2.6e-05	0.00188	CbGpPWpGaD
Prednisone—Dizziness—Montelukast—chronic obstructive pulmonary disease	2.6e-05	0.000624	CcSEcCtD
Prednisone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	2.59e-05	0.000623	CcSEcCtD
Prednisone—HSD11B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.59e-05	0.00188	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	2.57e-05	0.00186	CbGpPWpGaD
Prednisone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	2.55e-05	0.000613	CcSEcCtD
Prednisone—Vomiting—Formoterol—chronic obstructive pulmonary disease	2.55e-05	0.000613	CcSEcCtD
Prednisone—Rash—Formoterol—chronic obstructive pulmonary disease	2.53e-05	0.000608	CcSEcCtD
Prednisone—Rash—Arformoterol—chronic obstructive pulmonary disease	2.53e-05	0.000608	CcSEcCtD
Prednisone—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	2.53e-05	0.00183	CbGpPWpGaD
Prednisone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	2.53e-05	0.000607	CcSEcCtD
Prednisone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	2.53e-05	0.000607	CcSEcCtD
Prednisone—Headache—Arformoterol—chronic obstructive pulmonary disease	2.51e-05	0.000604	CcSEcCtD
Prednisone—Headache—Formoterol—chronic obstructive pulmonary disease	2.51e-05	0.000604	CcSEcCtD
Prednisone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	2.51e-05	0.000603	CcSEcCtD
Prednisone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	2.51e-05	0.000602	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	2.51e-05	0.00181	CbGpPWpGaD
Prednisone—Vomiting—Montelukast—chronic obstructive pulmonary disease	2.5e-05	0.0006	CcSEcCtD
Prednisone—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	2.49e-05	0.0018	CbGpPWpGaD
Prednisone—Rash—Montelukast—chronic obstructive pulmonary disease	2.48e-05	0.000595	CcSEcCtD
Prednisone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	2.48e-05	0.000595	CcSEcCtD
Prednisone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	2.47e-05	0.000593	CcSEcCtD
Prednisone—Headache—Montelukast—chronic obstructive pulmonary disease	2.46e-05	0.000591	CcSEcCtD
Prednisone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	2.43e-05	0.000584	CcSEcCtD
Prednisone—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	2.43e-05	0.00176	CbGpPWpGaD
Prednisone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	2.41e-05	0.000578	CcSEcCtD
Prednisone—Malaise—Prednisolone—chronic obstructive pulmonary disease	2.4e-05	0.000577	CcSEcCtD
Prednisone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	2.39e-05	0.000574	CcSEcCtD
Prednisone—Rash—Salbutamol—chronic obstructive pulmonary disease	2.39e-05	0.000574	CcSEcCtD
Prednisone—Syncope—Prednisolone—chronic obstructive pulmonary disease	2.39e-05	0.000573	CcSEcCtD
Prednisone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	2.39e-05	0.000573	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	2.38e-05	0.00173	CbGpPWpGaD
Prednisone—Nausea—Formoterol—chronic obstructive pulmonary disease	2.38e-05	0.000572	CcSEcCtD
Prednisone—Nausea—Arformoterol—chronic obstructive pulmonary disease	2.38e-05	0.000572	CcSEcCtD
Prednisone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	2.38e-05	0.00172	CbGpPWpGaD
Prednisone—Headache—Salbutamol—chronic obstructive pulmonary disease	2.37e-05	0.00057	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	2.35e-05	0.0017	CbGpPWpGaD
Prednisone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	2.34e-05	0.000562	CcSEcCtD
Prednisone—Nausea—Montelukast—chronic obstructive pulmonary disease	2.33e-05	0.000561	CcSEcCtD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	2.32e-05	0.00168	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	2.32e-05	0.00168	CbGpPWpGaD
Prednisone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	2.31e-05	0.000554	CcSEcCtD
Prednisone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	2.3e-05	0.000552	CcSEcCtD
Prednisone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	2.29e-05	0.00166	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	2.29e-05	0.00166	CbGpPWpGaD
Prednisone—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.28e-05	0.00165	CbGpPWpGaD
Prednisone—Nausea—Salbutamol—chronic obstructive pulmonary disease	2.25e-05	0.00054	CcSEcCtD
Prednisone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	2.24e-05	0.000538	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.22e-05	0.00161	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	2.22e-05	0.00161	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	2.22e-05	0.00161	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	2.2e-05	0.0016	CbGpPWpGaD
Prednisone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	2.17e-05	0.000522	CcSEcCtD
Prednisone—Oedema—Prednisolone—chronic obstructive pulmonary disease	2.17e-05	0.000522	CcSEcCtD
Prednisone—Shock—Prednisolone—chronic obstructive pulmonary disease	2.14e-05	0.000513	CcSEcCtD
Prednisone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	2.12e-05	0.000509	CcSEcCtD
Prednisone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	2.1e-05	0.000504	CcSEcCtD
Prednisone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	2.09e-05	0.00151	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	2.05e-05	0.00149	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	2.04e-05	0.00148	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	2.03e-05	0.00147	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2e-05	0.00145	CbGpPWpGaD
Prednisone—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	1.98e-05	0.00144	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.98e-05	0.00143	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	1.97e-05	0.00143	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	1.97e-05	0.00143	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	1.97e-05	0.00143	CbGpPWpGaD
Prednisone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	1.97e-05	0.000472	CcSEcCtD
Prednisone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	1.95e-05	0.000469	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	1.94e-05	0.0014	CbGpPWpGaD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	1.88e-05	0.00136	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	1.87e-05	0.00136	CbGpPWpGaD
Prednisone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	1.79e-05	0.00043	CcSEcCtD
Prednisone—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	1.77e-05	0.00128	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.76e-05	0.00127	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	1.73e-05	0.00125	CbGpPWpGaD
Prednisone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	1.73e-05	0.000415	CcSEcCtD
Prednisone—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	1.71e-05	0.00124	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	1.69e-05	0.00123	CbGpPWpGaD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	1.69e-05	0.00122	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.68e-05	0.00122	CbGpPWpGaD
Prednisone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	1.67e-05	0.00121	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.00121	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.64e-05	0.00119	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	1.61e-05	0.00117	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	1.6e-05	0.00116	CbGpPWpGaD
Prednisone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	1.6e-05	0.000384	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	1.6e-05	0.00116	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.58e-05	0.00115	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	1.57e-05	0.00114	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.57e-05	0.00114	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	1.5e-05	0.00109	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.47e-05	0.00106	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	1.46e-05	0.00106	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.46e-05	0.00106	CbGpPWpGaD
Prednisone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	1.44e-05	0.000345	CcSEcCtD
Prednisone—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	1.43e-05	0.00104	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.43e-05	0.00104	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.41e-05	0.00102	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	1.41e-05	0.00102	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.39e-05	0.00101	CbGpPWpGaD
Prednisone—Rash—Prednisolone—chronic obstructive pulmonary disease	1.37e-05	0.000329	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	1.37e-05	0.000992	CbGpPWpGaD
Prednisone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	1.37e-05	0.000329	CcSEcCtD
Prednisone—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.37e-05	0.000992	CbGpPWpGaD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.37e-05	0.000991	CbGpPWpGaD
Prednisone—Headache—Prednisolone—chronic obstructive pulmonary disease	1.36e-05	0.000327	CcSEcCtD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	1.35e-05	0.000975	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.33e-05	0.000962	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	1.31e-05	0.000952	CbGpPWpGaD
Prednisone—Nausea—Prednisolone—chronic obstructive pulmonary disease	1.29e-05	0.00031	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	1.29e-05	0.000932	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000924	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	1.27e-05	0.000923	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.000919	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.26e-05	0.000911	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	1.22e-05	0.000881	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000876	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.2e-05	0.000872	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.19e-05	0.000864	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.19e-05	0.000862	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	1.19e-05	0.000862	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	1.18e-05	0.000856	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	1.16e-05	0.000843	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	1.16e-05	0.000843	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	1.15e-05	0.000836	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.14e-05	0.000825	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	1.11e-05	0.000806	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	1.11e-05	0.000803	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	1.1e-05	0.000799	CbGpPWpGaD
Prednisone—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	1.08e-05	0.000785	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	1.07e-05	0.000774	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.06e-05	0.000767	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	1.03e-05	0.000746	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	1.03e-05	0.000743	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	1.02e-05	0.000737	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	1.02e-05	0.000737	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1e-05	0.000725	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.87e-06	0.000715	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	9.73e-06	0.000705	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	9.53e-06	0.000691	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	9.49e-06	0.000688	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	9.45e-06	0.000685	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	9.39e-06	0.00068	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	9.24e-06	0.00067	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	8.9e-06	0.000645	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	8.83e-06	0.00064	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	8.81e-06	0.000639	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.34e-06	0.000605	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.23e-06	0.000596	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	7.91e-06	0.000573	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.81e-06	0.000566	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.72e-06	0.00056	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.72e-06	0.000559	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	7.69e-06	0.000557	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.67e-06	0.000556	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.56e-06	0.000548	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	7.5e-06	0.000544	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	7.46e-06	0.00054	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.27e-06	0.000527	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	7.22e-06	0.000523	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.19e-06	0.000521	CbGpPWpGaD
Prednisone—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.18e-06	0.00052	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.17e-06	0.000519	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	7.13e-06	0.000516	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.12e-06	0.000516	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.04e-06	0.00051	CbGpPWpGaD
Prednisone—ALB—Metabolism—GC—chronic obstructive pulmonary disease	6.98e-06	0.000506	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.93e-06	0.000502	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.84e-06	0.000496	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	6.83e-06	0.000495	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	6.72e-06	0.000487	CbGpPWpGaD
Prednisone—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.49e-06	0.00047	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.49e-06	0.00047	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.44e-06	0.000467	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.39e-06	0.000463	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.29e-06	0.000456	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	6.27e-06	0.000454	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	6.12e-06	0.000443	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.85e-06	0.000424	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.83e-06	0.000422	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.69e-06	0.000412	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.57e-06	0.000403	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.41e-06	0.000392	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.34e-06	0.000387	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.17e-06	0.000375	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	5.16e-06	0.000374	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	5.09e-06	0.000369	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.08e-06	0.000368	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	5e-06	0.000362	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.97e-06	0.00036	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.88e-06	0.000353	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	4.74e-06	0.000343	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.71e-06	0.000341	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.67e-06	0.000338	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.64e-06	0.000336	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	4.59e-06	0.000333	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.57e-06	0.000331	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.36e-06	0.000316	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.87e-06	0.000281	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.87e-06	0.00028	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.84e-06	0.000278	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.81e-06	0.000276	CbGpPWpGaD
Prednisone—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	3.77e-06	0.000273	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.77e-06	0.000273	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.69e-06	0.000268	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.5e-06	0.000254	CbGpPWpGaD
Prednisone—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	3.44e-06	0.000249	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.42e-06	0.000248	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	3.38e-06	0.000245	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.34e-06	0.000242	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.3e-06	0.000239	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	3.29e-06	0.000238	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.2e-06	0.000232	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.17e-06	0.00023	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.16e-06	0.000229	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	3.09e-06	0.000224	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.06e-06	0.000222	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.01e-06	0.000218	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.93e-06	0.000212	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.85e-06	0.000206	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.78e-06	0.000201	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.66e-06	0.000193	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.64e-06	0.000192	CbGpPWpGaD
Prednisone—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.61e-06	0.000189	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.44e-06	0.000177	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.43e-06	0.000176	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.37e-06	0.000172	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.34e-06	0.00017	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.32e-06	0.000168	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.3e-06	0.000167	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.28e-06	0.000165	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.18e-06	0.000158	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.13e-06	0.000154	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.07e-06	0.00015	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.06e-06	0.000149	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.04e-06	0.000147	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.02e-06	0.000146	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	2.01e-06	0.000146	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.86e-06	0.000135	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.71e-06	0.000124	CbGpPWpGaD
Prednisone—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	1.5e-06	0.000108	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.43e-06	0.000103	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.41e-06	0.000102	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.41e-06	0.000102	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.37e-06	9.94e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.34e-06	9.74e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.31e-06	9.51e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.31e-06	9.5e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.24e-06	9.01e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	8.45e-07	6.12e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	8.08e-07	5.86e-05	CbGpPWpGaD
